These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7113779)

  • 1. Metabolic effects of pyridoxine alpha-ketoglutarate in ophthalmoplegia plus.
    Scarlato G; Pellegrini G; Moggio M; Ferini Strambi L
    Acta Neurol (Napoli); 1982 Apr; 4(2):92-7. PubMed ID: 7113779
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of pyruvic and lactic acidaemia in ophthalmoplegia plus.
    Scarlato G; Moggio M; Fici F; Cerri C
    Adv Exp Med Biol; 1982; 153():487-500. PubMed ID: 6762056
    [No Abstract]   [Full Text] [Related]  

  • 3. Ophthalmoplegia plus: neuropathological and metabolic studies with a therapeutic trial in seven cases.
    Pellegrini G; Scarlato G; Moggio M
    Acta Neuropathol Suppl; 1981; 7():317-9. PubMed ID: 6939262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of pyridoxine alpha-ketoglutarate on blood glucose and lactate in type I and II diabetics.
    Passariello N; Fici F; Giugliano D; Ceriello A; Dello Russo P; Sgambato S
    Int J Clin Pharmacol Ther Toxicol; 1983 May; 21(5):252-6. PubMed ID: 6862730
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of pyridoxine alpha-ketoglutarate (PAK) on ammonia and pyruvic and lactic acid blood levels in patients with cirrhosis.
    Salerno F; Abbiati R; Fici F
    Int J Clin Pharmacol Res; 1983; 3(1):21-5. PubMed ID: 6679504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pyridoxine-2-oxoglutarate administration in patients with advanced cirrhosis: control of ammonia pyruvate and lactate high plasma concentrations.
    Salerno F; Lorenzini MC; Conti M; Abbiati R; Fici F
    Adv Exp Med Biol; 1982; 153():479-85. PubMed ID: 6762055
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of hyperlactacidemia in cirrhotic patients with pyridoxine-alpha-ketoglutarate (PAK).
    Belvisi A; Matergi M; Fici F
    Int J Clin Pharmacol Ther Toxicol; 1982 Mar; 20(3):142-6. PubMed ID: 7068288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lactate and pyruvate blood levels in the diagnosis of mitochondrial myopathies].
    Zierz S; Meessen S; Jerusalem F
    Nervenarzt; 1989 Sep; 60(9):545-8. PubMed ID: 2812158
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ophthalmoplegia plus. On nosologic, biochemical, morphologic and computer tomographic aspects of the oculocraniosomatic syndrome].
    Lössner J; Lehmann W; Kühn HJ; Ziegan J; Brehme M
    Psychiatr Neurol Med Psychol Beih; 1983; 29():184-95. PubMed ID: 6415699
    [No Abstract]   [Full Text] [Related]  

  • 10. [A case of mitochondrial encephalomyopathy with myoclonic attacks, hyper-lactic-pyruvic acidemia, and decreased activities of complex II and cytochrome c oxidase].
    Harigaya Y; Shoji M; Okamoto K; Hirai S; Sato T
    Rinsho Shinkeigaku; 1988 Jan; 28(1):24-31. PubMed ID: 2838211
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of pyridoxine-alpha-ketoglutarate (PAK) on exercise-induced increase of blood lactate in patients with type I diabetes.
    Dall'Aglio E; Zavaroni I; Alpi O; Coscelli C; Butturini U
    Int J Clin Pharmacol Ther Toxicol; 1982 Mar; 20(3):147-50. PubMed ID: 7068289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oculo cranio-somatic syndrome: mitochondrial alterations and lactic acidemia.
    Angelini C; Armani M; Lücke S; Negrin P
    Acta Neurol (Napoli); 1979 Feb; 1(1):59-63. PubMed ID: 433682
    [No Abstract]   [Full Text] [Related]  

  • 13. Childhood mitochondrial myopathy with ophthalmoplegia.
    Land JM; Hockaday JM; Hughes JT; Ross BD
    J Neurol Sci; 1981 Sep; 51(3):371-82. PubMed ID: 7276984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction of increased plasma pyruvate and plasma lactate levels using large doses of thiamine in patients with Kearns-Sayre syndrome.
    Lou HC
    Arch Neurol; 1981 Jul; 38(7):469. PubMed ID: 7247778
    [No Abstract]   [Full Text] [Related]  

  • 15. Pyridoxine-alpha-ketoglutarate in the treatment of experimental lactic acidosis in the rat.
    Capretti L; Fici F; Coscelli C; Butturini U
    Horm Metab Res; 1981 Aug; 13(8):472-3. PubMed ID: 7327528
    [No Abstract]   [Full Text] [Related]  

  • 16. [Lactic and pyruvic acid levels and lactate dehydrogenase activity in the blood in stroke].
    Ishchenko MM; Dorogiĭ AN; Shkrobot SI
    Vrach Delo; 1984 Jan; (1):86-9. PubMed ID: 6702178
    [No Abstract]   [Full Text] [Related]  

  • 17. [Lactic acid, pyruvic acid, and citric acid in "blood"].
    JULICH H
    Z Kreislaufforsch; 1961 Jun; 50():606-8. PubMed ID: 13790999
    [No Abstract]   [Full Text] [Related]  

  • 18. [Variations of blood lactic acid and pyruvic acid during anesthesia].
    DE BONIS B; GOFFRINI M
    Boll Soc Med Chir Cremona; 1960; 14():71-80. PubMed ID: 13814678
    [No Abstract]   [Full Text] [Related]  

  • 19. [Blood levels of adenine nucleotides and lactic and pyruvic acids in pregnancy].
    Floka EI
    Akush Ginekol (Mosk); 1985 Oct; (10):59. PubMed ID: 2935014
    [No Abstract]   [Full Text] [Related]  

  • 20. [Indicators of exertion metabolism in parturients].
    Brodziński W
    Wiad Lek; 1985 Feb; 38(4):277-82. PubMed ID: 4013292
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.